Diplomat Pharmacy Inc Revenue Growth Rates (DPLO), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Diplomat Pharmacy Inc   (NYSE: DPLO)
 

DPLO's Revenue Growth by Quarter and Year

Diplomat Pharmacy Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

DPLO Revenue (in millions $) FY 2019 FY 2018 FY 2017 FY 2016
4th Quarter December -
3rd Quarter September 1,301.20
2nd Quarter June 1,287.62
1st Quarter March 1,256.81
FY 3,845.63

DPLOs Annual Revenue
Diplomat Pharmacy Inc 's Revenue in the fiscal year 2018 $ 5,492.52 millions
Diplomat Pharmacy Inc 's Revenue in the fiscal year 2017 $ 4,485.23 millions
Diplomat Pharmacy Inc 's Revenue in the fiscal year 2016 $ 4,410.39 millions
Diplomat Pharmacy Inc 's Revenue in the fiscal year 2015 $ 3,366.63 millions
Diplomat Pharmacy Inc 's Revenue in the fiscal year 2014 $ 2,214.96 millions




DPLO Revenue third quarter 2019 Y/Y Growth Comment
Diplomat Pharmacy Inc reported decrease in Revenue in the third quarter 2019 by -5.25% to $ 1,301.20 millions, from the same quarter in 2018.
The decrease in the third quarter 2019 Diplomat Pharmacy Inc 's Revenue compares unfavorably to the Company's average Revenue rise of 26.05%.

Looking into third quarter 2019 results within Pharmacy Services & Retail Drugstore industry 14 other companies have achieved higher Revenue growth. While Diplomat Pharmacy Inc ' s Revenue decline of -5.25% ranks overall at the positon no. 3250 in the third quarter 2019.


DPLO Revenue ( Y/Y Growth %) 2019
 2018 2017 2016
4th Quarter December - 17.8 % 0.89 % 16.01 %
3rd Quarter September -5.25 % 22.08 % -4.76 % 24.74 %
2nd Quarter June -9.07 % 25.71 % 3.49 % 34.71 %
1st Quarter March -6.38 % 24.45 % 8.32 % 59.37 %
FY   - 22.46 % 1.7 % -

Financial Statements
Diplomat Pharmacy Inc 's third quarter 2019 Revenue $ 1,301.20 millions DPLO's Income Statement
Diplomat Pharmacy Inc 's third quarter 2018 Revenue $ 1,373.33 millions Quarterly DPLO's Income Statement


DPLO Revenue (Quarter on Quarter Growth %)

 2019
 2018 2017 2016
4th Quarter December - -0.92 % 2.68 % -3.08 %
3rd Quarter September 1.05 % -3.02 % -0.13 % 8.51 %
2nd Quarter June 2.45 % 5.48 % 4.42 % 9.3 %
1st Quarter March -7.63 % 16.22 % -5.77 % 0.92 %
FY (Year on Year)   - 22.46 % 1.7 % -


Back to DPLO Growth rate Comparisons >> Back to DPLO Growth rate Comparisons >>


Revenue third quarter 2019 Y/Y Growth Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry #15
Retail Sector #172
Overall #3250

Revenue Y/Y Growth Statistics
High Average Low
61.23 % 26.05 % -9.07 %
(Mar 31 2016)  
Revenue third quarter 2019 Y/Y Growth Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry #15
Retail Sector #172
Overall #3250
Revenue Y/Y Growth Statistics
High Average Low
61.23 % 26.05 % -9.07 %
(Mar 31 2016)  

Revenue by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

Diplomat Pharmacy Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
29.31 % 4.51 % -7.63 %
(Jun 30 2015)  


DPLO's III. Quarter Q/Q Revenue Comment
Diplomat Pharmacy Inc achieved in the III. Quarter 2019 below company average Revenue growth of 1.05% quarter on quarter, to $ 1,301.20 millions.

Although the III. Quarter 2019 Revenue Q/Q growth was lower than the regular , this has been yet encouraging story, as the III. Quarter surge, eclipses the -3.02% growth in the III. Quarter a year ago

Within Pharmacy Services & Retail Drugstore industry 9 other companies have achieved higher Revenue quarter on quarter growth. While Diplomat Pharmacy Inc 's Revenue growth quarter on quarter, overall rank is 2617.


Revenue Q/Q Growth Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry #10
Retail Sector #131
Overall #2617
Revenue Q/Q Growth Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry #10
Retail Sector #131
Overall #2617
Revenue Q/Q Growth Statistics
High Average Low
29.31 % 4.51 % -7.63 %
(Jun 30 2015)  


DPLO's III. Quarter Q/Q Revenue Comment
Diplomat Pharmacy Inc achieved in the III. Quarter 2019 below company average Revenue growth of 1.05% quarter on quarter, to $ 1,301.20 millions.

III. Quarter 2019 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the -3.02% in the III. Quarter a year ago.

Within Pharmacy Services & Retail Drugstore industry 9 other companies have achieved higher Revenue quarter on quarter growth. While Diplomat Pharmacy Inc 's Revenue growth quarter on quarter, overall rank is 2617.


Diplomat Pharmacy Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2019)		 12 Months Ending
(Jun 30 2019)		 12 Months Ending
(Mar 31 2019)		 12 Months Ending
(Dec 31 2018)		 12 Months Ending
(Sep 30 2018)
Cumulative Revenue 12 Months Ending $ 5,206.26 $ 5,278.39 $ 5,406.85 $ 5,492.52 $ 5,286.97
Y / Y Revenue Growth (TTM) -1.53 % 4.76 % 13.85 % 22.46 % 18.14 %
Year on Year Revenue Growth Overall Ranking # 979 # 1762 # 1117 # 1630 # 999
Seqeuential Revenue Change (TTM) -1.37 % -2.38 % -1.56 % 3.89 % 4.93 %
Seq. Revenue Growth (TTM) Overall Ranking # 1994 # 2669 # 2595 # 3137 # 1017


Cumulative Revenue growth Comment
For the 12 months ended Sep 30 2019 Diplomat Pharmacy Inc reported a decrease in Revenue by -1.53% year on year, to $5,206 millions, compare to the 4.76% growth at Jun 30 2019.

Within the Retail sector 28 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 979, from total ranking in previous quarter at 1762.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry # 9
Retail Sector # 29
Overall # 979

Revenue TTM Y/Y Growth Statistics
High Average Low
42.92 %
 14.82 %
-1.53 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 9
Sector # 75
S&P 500 # 1994
Cumulative Revenue growth Comment
For the 12 months ended Sep 30 2019 Diplomat Pharmacy Inc reported a decrease in Revenue by -1.53% year on year, to $5,206 millions, compare to the 4.76% growth at Jun 30 2019.

Within the Retail sector 28 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 979, from total ranking in previous quarter at 1762.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry # 9
Retail Sector # 29
Overall # 979

Revenue TTM Y/Y Growth Statistics
High Average Low
42.92 %
14.82 %
-1.53 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 9
Sector # 75
S&P 500 # 1994




Other Revenue Growth
Pharmacy Services & Retail Drugstore Industry Revenue Growth Trends and Statistics
Retail Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
DPLO's Revenue Growth Ratio versus Pharmacy Services & Retail Drugstore Industry, Retail Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue decrease for the quarter ending Sep 30 2019 within Retail SectorY/Y Change %Revenue for the quarter ending Sep 30 2019
Sally Beauty Holdings Inc -0.01%$ -0.006 millions
Big 5 Sporting Goods Corporation-0.08%$ -0.075 millions
Marinemax Inc -0.15%$ -0.147 millions
Carparts com Inc -0.27%$ -0.274 millions
Tuesday Morning Corp-1.26%$ -1.264 millions
Haverty Furniture Companies Inc-1.57%$ -1.575 millions
Petmed Express Inc -2.04%$ -2.045 millions
Party City Holdco Inc -2.32%$ -2.317 millions
Ll Flooring Holdings Inc -2.41%$ -2.407 millions
Qvc inc -2.53%$ -2.530 millions
Amerinac Holding Corp -3.14%$ -3.139 millions
Murphy Usa Inc -3.44%$ -3.442 millions
The Odp Corporation-3.64%$ -3.637 millions
Rave Restaurant Group Inc -3.84%$ -3.845 millions
Rito Group Corp -3.88%$ -3.883 millions
School Specialty Inc-4.05%$ -4.054 millions
Qvc Group Inc -4.39%$ -4.395 millions
Diplomat Pharmacy Inc -5.25%$ -5.253 millions
Travelcenters Of America Inc -5.36%$ -5.358 millions
Ezcorp Inc -6.45%$ -6.448 millions
Builders Firstsource Inc -6.49%$ -6.487 millions
Free Flow Usa Inc -8.42%$ -8.421 millions
Suburban Propane Partners Lp-10.84%$ -10.837 millions
Live Ventures Inc-12.11%$ -12.108 millions
Nu Skin Enterprises Inc -12.64%$ -12.643 millions
Youngevity International Inc.-14.59%$ -14.590 millions
Industrial Services Of America Inc-22.81%$ -22.812 millions
Ifresh Inc-28.26%$ -28.256 millions
Blue Apron Holdings Inc -33.95%$ -33.947 millions
Aiadvertising Inc-37.68%$ -37.685 millions


About Diplomat Pharmacy Inc Revenue Growth Rates (DPLO), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.